Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Inositol Metabolism | R-HSA-1483249 | 0 | Fe2+ | 439260 | smpdb |
| Dihydropyrimidinase Deficiency | R-HSA-5602680 | 0 | Fe2+ | 439260 | smpdb |
| Familial Hypercholanemia | R-HSA-5682111 | 0 | Fe2+ | 439260 | smpdb |
| Zoledronate Action Pathway | R-HSA-9639775 | 0 | Fe2+ | 439260 | smpdb |
| Congenital Bile Acid Synthesis Defect Type II | R-HSA-194068 | 0 | Fe2+ | 439260 | smpdb |
| Congenital Erythropoietic Porphyria or Gunther Disease | 0 | 0 | Fe2+ | 439260 | smpdb |
| Simvastatin Action Pathway | R-ALL-9705597 | 0 | Fe2+ | 439260 | smpdb |
| Galactosemia | R-HSA-5610038 | 0 | Fe2+ | 439260 | smpdb |
| Tryptophan Metabolism | R-HSA-71240 | map00380 | Fe2+ | 439260 | smpdb |
| Congenital Disorder of Glycosylation CDG-IId | R-HSA-5619078 | 0 | Fe2+ | 439260 | smpdb |
| Fluvastatin Action Pathway | R-ALL-9705591 | 0 | Fe2+ | 439260 | smpdb |
| Chondrodysplasia Punctata II, X-Linked Dominant | 0 | 0 | Fe2+ | 439260 | smpdb |
| Porphyrin Metabolism | R-ALL-1369066 | map00860 | Fe2+ | 439260 | smpdb |
| Refsum Disease | R-HSA-1643685 | 0 | Fe2+ | 439260 | smpdb |
| Wolman Disease | R-HSA-1643685 | 0 | Fe2+ | 439260 | smpdb |
| Cystinosis, Ocular Nonnephropathic | R-HSA-5619054 | 0 | Fe2+ | 439260 | smpdb |
| Desmosterolosis | R-HSA-196417 | 0 | Fe2+ | 439260 | smpdb |
| 27-Hydroxylase Deficiency | R-HSA-5602680 | 0 | Fe2+ | 439260 | smpdb |
| The Oncogenic Action of Fumarate | R-HSA-6802957 | 0 | Fe2+ | 439260 | smpdb |
| Aromatic L-Aminoacid Decarboxylase Deficiency | R-HSA-2167848 | 0 | Fe2+ | 439260 | smpdb |